# Sector Gamma As 13F holdings Q2 2026: $461 million

Sector Gamma As reported $461 million in 13F securities across 40 positions for the quarter ended June 30, 2026, in a holdings report filed August 12, 2026. Its largest holding was Bristol-Myers Squibb Co at $41.8 million, 9.1% of the reported value. Since Q1 2026 it opened 7 new positions and exited 9.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $460,970,513
- Positions: 40
- Filed: August 12, 2026
- Report type: 13F holdings report
- CIK: 1475373
- Form 13F file number: 028-13612
- Business address: Kristian Augusts Gate 15c P.O. Box 462 Sentrum, Oslo, 0105 Norway
- SEC filing: [0000945621-26-001027](https://www.sec.gov/Archives/edgar/data/1475373/000094562126001027/0000945621-26-001027-index.htm)

## Top 25 holdings by value

The largest of 40 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Bristol-Myers Squibb Co](https://specstream.ai/data/institutional-holders/bristol-myers-squibb-co-110122108) | COM | 726,115 | $41.8 million | -101,786 |
| [Merck & Co Inc](https://specstream.ai/data/institutional-holders/merck-co-inc-58933y105) | COM | 217,008 | $27.9 million | -43,332 |
| [Medtronic PLC](https://specstream.ai/data/institutional-holders/medtronic-plc-g5960l103) | SHS | 352,437 | $27.6 million | +71,755 |
| [Pfizer Inc](https://specstream.ai/data/institutional-holders/pfizer-inc-717081103) | COM | 1,004,215 | $24.2 million | -87,170 |
| [Incyte Corp](https://specstream.ai/data/institutional-holders/incyte-corp-45337c102) | COM | 170,753 | $19.4 million | -29,757 |
| [Elevance Health Inc Formerly](https://specstream.ai/data/institutional-holders/elevance-health-inc-formerly-036752103) | COM | 44,499 | $17.2 million | +537 |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 294,918 | $16.9 million | +55,000 |
| [Thermo Fisher Scientific Inc](https://specstream.ai/data/institutional-holders/thermo-fisher-scientific-inc-883556102) | COM | 33,584 | $16.8 million | New |
| [CVS Health Corp](https://specstream.ai/data/institutional-holders/cvs-health-corp-126650100) | COM | 155,337 | $16.1 million | +20,000 |
| [Iqvia Hldgs Inc](https://specstream.ai/data/institutional-holders/iqvia-hldgs-inc-46266c105) | COM | 77,944 | $15.1 million | +37,714 |
| [Ionis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ionis-pharmaceuticals-inc-462222100) | COM | 189,468 | $15 million | +20,000 |
| [Becton Dickinson & Co](https://specstream.ai/data/institutional-holders/becton-dickinson-co-075887109) | COM | 93,168 | $14.1 million | +10,553 |
| [Abbott Laboratories](https://specstream.ai/data/institutional-holders/abbott-laboratories-002824100) | COM | 147,444 | $13.4 million | +59,912 |
| [Ge Healthcare Technologies I](https://specstream.ai/data/institutional-holders/ge-healthcare-technologies-i-36266g107) | COMMON STOCK | 207,863 | $13.3 million | +81,445 |
| [Zimmer Biomet Holdings Inc](https://specstream.ai/data/institutional-holders/zimmer-biomet-holdings-inc-98956p102) | COM | 142,307 | $12.3 million | -13,528 |
| [Biogen Inc](https://specstream.ai/data/institutional-holders/biogen-inc-09062x103) | COM | 54,163 | $11.7 million | -35,933 |
| [Qiagen NV](https://specstream.ai/data/institutional-holders/qiagen-nv-n72482156) | ORD SHARES | 287,640 | $11.2 million | +125,269 |
| [Centene Corp Del](https://specstream.ai/data/institutional-holders/centene-corp-del-15135b101) | COM | 162,405 | $10.4 million | No change |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/institutional-holders/regeneron-pharmaceuticals-75886f107) | COM | 15,780 | $9.8 million | New |
| [Bio Rad Labs Inc](https://specstream.ai/data/institutional-holders/bio-rad-labs-inc-090572207) | CL A | 33,350 | $9.8 million | +9,600 |
| [Cardinal Health Inc](https://specstream.ai/data/institutional-holders/cardinal-health-inc-14149y108) | COM | 40,689 | $9.7 million | -14,208 |
| [Amgen Inc](https://specstream.ai/data/institutional-holders/amgen-inc-031162100) | COM | 26,281 | $9.5 million | -20,874 |
| [Bruker Corp](https://specstream.ai/data/institutional-holders/bruker-corp-116794108) | COM | 152,352 | $9.2 million | -101,658 |
| [Avantor Inc](https://specstream.ai/data/institutional-holders/avantor-inc-05352a100) | COM | 906,088 | $9 million | +210,685 |
| [PTC Therapeutics Inc](https://specstream.ai/data/institutional-holders/ptc-therapeutics-inc-69366j200) | COM | 100,000 | $8.2 million | +25,000 |

## New positions in Q2 2026

7 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Thermo Fisher Scientific Inc](https://specstream.ai/data/institutional-holders/thermo-fisher-scientific-inc-883556102) | COM | 33,584 | $16.8 million |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/institutional-holders/regeneron-pharmaceuticals-75886f107) | COM | 15,780 | $9.8 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 21,305 | $5.7 million |
| [Boston Scientific Corp](https://specstream.ai/data/institutional-holders/boston-scientific-corp-101137107) | COM | 121,128 | $5.2 million |
| [Travere Therapeutics Inc](https://specstream.ai/data/institutional-holders/travere-therapeutics-inc-89422g107) | COM | 80,000 | $4.5 million |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 45,000 | $3.8 million |
| [Intellia Therapeutics Inc](https://specstream.ai/data/institutional-holders/intellia-therapeutics-inc-45826j105) | COM | 185,177 | $3.1 million |

## Positions exited in Q2 2026

9 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 36,435 | $9.9 million |
| [Gilead Sciences Inc](https://specstream.ai/data/institutional-holders/gilead-sciences-inc-375558103) | COM | 53,247 | $7.4 million |
| [Lantheus Hldgs Inc](https://specstream.ai/data/institutional-holders/lantheus-hldgs-inc-516544103) | COM | 93,344 | $7.1 million |
| Ascendis Pharma A/S | SPONSORED ADR | 21,305 | $4.9 million |
| [Humana Inc](https://specstream.ai/data/institutional-holders/humana-inc-444859102) | COM | 19,202 | $3.3 million |
| [Bridgebio Pharma Inc](https://specstream.ai/data/institutional-holders/bridgebio-pharma-inc-10806x102) | COM | 44,263 | $3.3 million |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 162,710 | $3.1 million |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 80,000 | $3.1 million |
| [Arrowhead Pharmaceuticals in](https://specstream.ai/data/institutional-holders/arrowhead-pharmaceuticals-in-04280a100) | COM | 30,000 | $1.9 million |

## Also on SpecStream

- [Sector Gamma As Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1475373/000094562126001027/0000945621-26-001027-index.htm)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Barbecue restaurants in the United States](https://specstream.ai/data/businesses/barbecue-restaurants/united-states)
- [Medical sciences schools in the United States](https://specstream.ai/data/businesses/medical-sciences-schools/united-states)
- [B2B mining companies in the United States](https://specstream.ai/data/businesses/b2b-mining-companies/united-states)
- [Litigation law firms in the United States](https://specstream.ai/data/businesses/litigation-law-firms/united-states)
- [Asian fusion restaurants in the United States](https://specstream.ai/data/businesses/asian-fusion-restaurants/united-states)
- [Jamaican restaurants in the United States](https://specstream.ai/data/businesses/jamaican-restaurants/united-states)
